U.S. markets close in 6 hours 3 minutes

Zoetis Inc. (ZTS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
202.24-2.55 (-1.25%)
As of 9:57AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close204.79
Bid200.14 x 1000
Ask200.96 x 1000
Day's Range195.61 - 202.86
52 Week Range141.41 - 207.00
Avg. Volume1,793,440
Market Cap96.017B
Beta (5Y Monthly)0.64
PE Ratio (TTM)54.51
Earnings DateN/A
Forward Dividend & Yield1.00 (0.49%)
Ex-Dividend DateJul 20, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-12% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Zacks

    Zoetis (ZTS) Surpasses Q2 Earnings and Revenue Estimates

    Zoetis (ZTS) delivered earnings and revenue surprises of 10.19% and 6.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • MarketWatch

    Zoetis reported profit and revenue rose above expectations, raised the full-year guidance

    Zoetis Inc. reported Thursday second-quarter profit and revenue that rose above expectations and lifted its full-year outlook, driven by petcare parasiticides, dermatology products, vaccines and diagnostics. The animal health company's stock slipped 0.4% in premarket trading, after closing Wednesday at a record. Net income rose to $512 million, or $1.07 a share, from $377 million, or 79 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share came to $1.19

  • Investor's Business Daily

    Zoetis Earnings Top Views For Animal-Health Giant

    Zoetis exceeded Q2 earnings and revenue estimates. Shares of the animal-health giant were little changed.